Related Experiment Videos
Baclofen analgesia in mice: a GABAB-mediated response.
1Department of Pharmaceutical Sciences, Panjab University, Chandigarh, India.
Methods and Findings in Experimental and Clinical Pharmacology
|December 1, 1991
Summary
Baclofen, a GABAB agonist, demonstrated dose-dependent antinociceptive effects in mice. Its analgesic action is mediated by GABAB receptors, with potential interactions with opioid pathways.
Area of Science:
- Pharmacology
- Neuroscience
- Pain Research
Background:
- Baclofen is a selective agonist for the GABAB receptor.
- GABAB receptors are implicated in modulating pain perception.
Purpose of the Study:
- To investigate the antinociceptive effects of baclofen.
- To determine the receptor mechanisms underlying baclofen's analgesia.
- To explore potential interactions with opioid and GABAergic systems.
Main Methods:
- Administered baclofen in three antinociceptive tests in mice: tail flick latency, hot plate, and acetic acid-induced writhing.
- Tested stereospecificity using the levo isomer.
- Evaluated interactions with antagonists: CGP 35348 (GABAB), naloxone (opioid), bicuculline, and picrotoxin (GABAA).
Main Results:
- Baclofen produced dose-dependent antinociception across all models.
- The levo isomer of baclofen was more potent than the racemic mixture, indicating stereospecificity.
- Baclofen potentiated morphine analgesia.
- Antinociception was reversed by GABAB and opioid antagonists, but not GABAA antagonists.
- Naloxone did not reverse analgesia in the acetic acid-induced writhing test.
Conclusions:
- Baclofen's antinociceptive effects are primarily mediated by GABAB receptors.
- Evidence suggests a complex interaction between GABAergic and opioid (or non-opioid) systems in mediating analgesia.
- The findings highlight GABAB receptors as a potential target for pain management.